TOP TEN perturbations for 38918_at (Homo sapiens)

Organism: Homo sapiens
Gene: 38918_at
Selected probe(set): 209736_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38918_at (209736_at) across 6674 perturbations tested by GENEVESTIGATOR:

skin squamous cell carcinoma study 6 / basal cell carcinoma study 2

Relative Expression (log2-ratio):-2.6901026
Number of Samples:4 / 2
Experimental skin squamous cell carcinoma study 6
Primary tumor tissue from the skin of patients with squamous cell carcinoma (SCC).
Control basal cell carcinoma study 2
Primary tumor tissue from the skin of patients with basal cell carcinoma (BCC).

glioma study 16 (LN-319) / normal astrocyte sample

Relative Expression (log2-ratio):2.543643
Number of Samples:2 / 3
Experimental glioma study 16 (LN-319)
Human glioma cell line LN319 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control normal astrocyte sample
Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Merkel cell carcinoma study 3 (primary) / basal cell carcinoma study 2

Relative Expression (log2-ratio):-2.4764614
Number of Samples:19 / 2
Experimental Merkel cell carcinoma study 3 (primary)
Primary tumor tissue from the skin of patients with Merkel cell carcinoma.
Control basal cell carcinoma study 2
Primary tumor tissue from the skin of patients with basal cell carcinoma (BCC).

basal cell carcinoma study 2 / normal skin tissue

Relative Expression (log2-ratio):2.3952007
Number of Samples:2 / 64
Experimental basal cell carcinoma study 2
Primary tumor tissue from the skin of patients with basal cell carcinoma (BCC).
Control normal skin tissue
Normal skin samples from healthy donors.

oligodendrocyte progenitor cell study 2 (O4-;CD140a+) / oligodendrocyte progenitor cell study 2 (O4-;CD140a-)

Relative Expression (log2-ratio):2.1452618
Number of Samples:5 / 5
Experimental oligodendrocyte progenitor cell study 2 (O4-;CD140a+)
Fetal oligodendrocyte cells between 20-22wk gestational age derived from fetal brains were FACS sorted on the basis of CD140a (PDGFRA) antigens. Samples were O4-/CD140a+.
Control oligodendrocyte progenitor cell study 2 (O4-;CD140a-)
Fetal oligodendrocyte cells between 20-22wk gestational age derived from fetal brains were FACS sorted on the basis of CD140a (PDGFRA) antigens. Samples were O4-/CD140a-.

E. coli study 1 / unstimulated, normal monocyte-derived macrophage sample

Relative Expression (log2-ratio):-1.876997
Number of Samples:12 / 16
Experimental E. coli study 1
Monocyte-derived macrophage samples derived from healthy control subjects cultured for 4 hours with 2.5 × 105 heat-killed E. coli.
Control unstimulated, normal monocyte-derived macrophage sample
Monocyte-derived macrophage samples derived from healthy control subjects cultured for 4 hours unstimulated.

prostate cancer study 8 (p. canc) / prostate cancer study 8 (ptasc)

Relative Expression (log2-ratio):-1.8299704
Number of Samples:3 / 2
Experimental prostate cancer study 8 (p. canc)
CD26+ FACS sorted prostate neoplasm cell (p. canc) samples from patients with primary prostate cancer collected after radical prostatectomy.
Control prostate cancer study 8 (ptasc)
CD90+ FACS sorted prostate tumor-associated stromal cell (ptasc) samples from patients with primary prostate cancer collected after radical prostatectomy.

stem cell differentiation study 41 (T3pi) / undifferentiated hES-T3 cell sample

Relative Expression (log2-ratio):-1.8278675
Number of Samples:2 / 3
Experimental stem cell differentiation study 41 (T3pi)
Sample of pancreatic islet-like cell clusters differentiated from human embryonic stem cells T3 with female karyotype.
Control undifferentiated hES-T3 cell sample
Undifferentiated human embryonic stem cells T3.

basal cell carcinoma study 6 (primary) / skin squamous cell carcinoma study 8 (primary)

Relative Expression (log2-ratio):1.6208553
Number of Samples:15 / 11
Experimental basal cell carcinoma study 6 (primary)
Primary tumor tissue from the skin of patients with primary basal cell carcinoma (BCC).
Control skin squamous cell carcinoma study 8 (primary)
Primary tumor tissue from the skin of patients with primary squamous cell carcinoma (SCC).

basal cell carcinoma study 6 (primary) / normal skin tissue

Relative Expression (log2-ratio):1.569746
Number of Samples:15 / 4
Experimental basal cell carcinoma study 6 (primary)
Primary tumor tissue from the skin of patients with primary basal cell carcinoma (BCC).
Control normal skin tissue
Normal skin tissue.